
12.81 Delayed Data As of Jun 09 | ![]() Today’s Change | 7.78 Today|||52-Week Range 13.84 | +4.91% Year-to-Date |
Why Is Amicus Therapeutics (FOLD) Up 8.1% Since Last Earnings Report? Jun 09 / Zacks.com - Paid Partner Content |
Previous close | 12.62 |
Today’s open | 12.62 |
Day’s range | 12.52 - 12.93 |
Volume | 65,787 |
Average volume (3 months) | 2,446,428 |
Market cap | $3.5B |
Earnings growth (last year) | +11.31% |
Earnings growth (this year) | +46.91% |
Earnings growth (next 5 years) | +65.42% |
Revenue growth (last year) | +7.76% |
P/E ratio | NM |
Price/Sales | 10.72 |
Price/Book | 27.77 |
Today’s change | Today’s % change | |
---|---|---|
RAREUltragenyx Pharmaceu... | -0.22 | -0.43% |
SAGESAGE Therapeutics In... | +2.88 | +5.08% |
---- | ||
KRYSKrystal Biotech Inc | +0.94 | +0.73% |
Next reporting date | August 3, 2023 |
EPS forecast (this quarter) | -$0.12 |
Annual revenue (last year) | $329.2M |
Annual profit (last year) | -$236.6M |
Net profit margin | -71.85% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Philadelphia, Pennsylvania |